Published in Biochem Pharmacol on March 15, 1985
Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol (1978) 1.33
Activation, inactivation, and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin. Proc Natl Acad Sci U S A (1980) 1.28
Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane. Proc Natl Acad Sci U S A (1980) 1.11
Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor. Mol Pharmacol (1980) 1.09
Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett (1990) 1.07
The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther (1990) 1.03
M3 muscarinic acetylcholine receptors regulate cytoplasmic myosin by a process involving RhoA and requiring conventional protein kinase C isoforms. J Biol Chem (1999) 1.01
Electrophysiological and biochemical studies on enhancement of desensitization by phenothiazine neuroleptics. Proc Natl Acad Sci U S A (1983) 0.96
[3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor. Proc Natl Acad Sci U S A (1980) 0.94
Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter. Neurosci Lett (1990) 0.94
Stereoselective muscarinic acetylcholine and opiate receptiors in human phagocytic leukocytes. Biochem Pharmacol (1980) 0.93
Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol (1995) 0.92
Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors. Mol Pharmacol (1989) 0.91
Conversion between configurational states of the muscarinic receptor in rat brain. Eur J Pharmacol (1977) 0.91
The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties. Mol Pharmacol (1984) 0.90
Evidence for a noncholinergic nicotine receptor on human phagocytic leukocytes. Mol Cell Biochem (1982) 0.90
Structural and stereochemical requirements for muscarinic receptor binding. Mol Pharmacol (1979) 0.90
Similarities in the binding sites of the muscarinic receptor and the ionic channel of the nicotinic receptor. Biochem Pharmacol (1980) 0.90
Sites of action of phencyclidine. I. Effects on the electrical excitability and chemosensitive properties of the neuromuscular junction of skeletal muscle. Mol Pharmacol (1980) 0.90
5,8-disubstituted indolizidines: a new class of noncompetitive blockers for nicotinic receptor-channels. Neurochem Res (1991) 0.89
Sites of action of phencyclidine. III. Interactions with muscarinic receptors. Mol Pharmacol (1980) 0.89
Nature of regional and chemically-induced differences in the binding properties of muscarinic acetylcholine receptors from rat brain. Neuropharmacology (1980) 0.89
Solubilization of muscarinic acetylcholine receptors of bovine brain. Life Sci (1978) 0.89
Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse. J Pharmacol Exp Ther (1986) 0.87
Interaction of gephyrotoxin and indolizidine alkaloids with the nicotinic acetylcholine receptor-ion channel complex of Torpedo electroplax. Neurochem Res (1986) 0.86
Effects of adenosine and analogs on adenylate cyclase activity in cultured bovine aortic endothelial cells. Biochem Pharmacol (1990) 0.85
Cholinergic supersensitivity and decreased number of muscarinic receptors in atria from short-term diabetic rats. J Mol Cell Cardiol (1984) 0.85
Ketamine inhibition of ligand binding to cholinergic receptors and ion channels. Eur J Pharmacol (1982) 0.84
Development of muscarinic cholinergic receptors in inbred strains of mice: identification of receptor heterogeneity and relation to audiogenic seizure susceptibility. Brain Res (1979) 0.84
Influence of N-ethylmaleimide on cholinoceptors and responses in longitudinal muscles from guinea-pig ileum. Br J Pharmacol (1982) 0.84
Changes in cholinergic parameters associated with failure of conotruncal septation in embryonic chick hearts after neural crest ablation. Circ Res (1985) 0.84
Muscarinic cholinergic binding in human erythrocyte membranes. Life Sci (1977) 0.84
Regulation of [3H]perhydrohistrionicotoxin binding to Torpedo ocellata electroplax by effectors of the acetylcholine receptor. J Biol Chem (1981) 0.84
Clonidine protection from soman and echothiophate toxicity in mice. Life Sci (1986) 0.84
Involvement of protein kinase C and protein kinase A in the muscarinic receptor signalling pathways mediating phospholipase C activation, arachidonic acid release and calcium mobilisation. Cell Signal (1999) 0.83
Fluidity in hydrophobic protein regions of synaptic membranes. Eur J Biochem (1974) 0.82
Increased muscarinic responsiveness and decreased muscarinic receptor content in ileal smooth muscle in diabetes. J Pharmacol Exp Ther (1990) 0.82
Decahydroquinoline alkaloids: noncompetitive blockers for nicotinic acetylcholine receptor-channels in pheochromocytoma cells and Torpedo electroplax. Neurochem Res (1991) 0.82
Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neurosci Lett (1989) 0.82
Kappa opioid receptors stimulate phosphoinositide turnover in rat brain. Life Sci (1990) 0.82
Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state. Neurochem Res (1986) 0.82
Effect of colchicine and taxol on stimulation of G protein GTPase activity in anterior pituitary lobe of rats by gonadotrophin- and thyrotrophin-releasing hormones. J Reprod Fertil (1993) 0.81
Interactions of tricyclic antidepressants with a synaptic ion channel. Life Sci (1981) 0.81
Opiates stimulate low Km GTPase in brain. J Neurochem (1984) 0.80
Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies. Mol Pharmacol (1984) 0.80
Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells. Mol Pharmacol (1985) 0.80
Effect of 2450 MHz microwave energy on the blood-brain barrier to hydrophilic molecules. A. Effect on the permeability to sodium fluorescein. Brain Res (1984) 0.79
Stereospecific morphine adsorption to phosphatidyl serine and other membranous components of brain. Eur J Pharmacol (1975) 0.79
A novel agonist binding site on nicotinic acetylcholine receptors. J Recept Res (1993) 0.79
Pyrazole, an alcohol dehydrogenase inhibitor, has dual effects on N-methyl-D-aspartate receptors of hippocampal pyramidal cells: agonist and noncompetitive antagonist. J Pharmacol Exp Ther (1992) 0.79
Reversible conversion between affinity states for agonists of the muscarinic acetylcholine receptor from rat brain. Biochem Pharmacol (1979) 0.79
Altered muscarinic receptor properties and function in the heart in diabetes. J Pharmacol Exp Ther (1987) 0.79
Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites. J Pharmacol Exp Ther (1991) 0.79
Separation of brain phosphatidylserines according to degree of unsaturation by thin-layer chromatography. Anal Biochem (1976) 0.79
Differential coupling between muscarinic receptors and G-proteins in regions of the rat brain. Biochem Pharmacol (1990) 0.79
Inhibition of carbachol-stimulated phosphoinositide turnover by U-50,488H in rat hippocampus--involvement of GTP-binding protein. Eur J Pharmacol (1991) 0.79
Selectivity of pirenzepine in the central nervous system. II. Differential effects of pirenzepine and scopolamine on performance of a representational memory task. Brain Res (1987) 0.79
Precursors of cholinergic false transmitters: central effects on blood pressure and direct interactions with cholinergic receptors. Neuropharmacology (1988) 0.78
Adrenergic agonists protect against soman, an irreversible acetylcholinesterase inhibitor. Toxicol Lett (1987) 0.78
Regional distribution of muscarinic receptors preferring gallamine in the rat brain. Biochem Pharmacol (1986) 0.78
[Physical and mental development of hypathyroid children being treated with synthetic thyroid hormone (author's transl)]. Dtsch Med Wochenschr (1974) 0.78
Benzomorphan interactions with acetylcholine receptor complexes from Torpedo. Eur J Pharmacol (1983) 0.78
Stereoselective binding and activity of oxotremorine analogs at muscarinic receptors in rat brain. Chirality (1992) 0.78
Regulation of beta-adrenergic receptor density in the non-innervated and denervated embryonic chick heart. J Mol Cell Cardiol (1986) 0.77
The influence of isoflurane on the synaptic activity of 5-hydroxytryptamine. Neurochem Res (1990) 0.77
Autoradiographic analyses of agonist binding to muscarinic receptor subtypes. Biochem Pharmacol (1989) 0.77
Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman. Neurotoxicol Teratol (1989) 0.77
Retinoic acid-induced differentiation of a human neuroblastoma cell line alters muscarinic receptor expression. Brain Res Dev Brain Res (1993) 0.77
Characterization of the muscarinic receptor subtypes in the bovine corneal epithelial cells. J Ocul Pharmacol Ther (1996) 0.77
Modulation of adenylate cyclase activity in cultured bovine pulmonary arterial endothelial cells. Effects of adenosine and derivatives. Biochem Pharmacol (1989) 0.77
Substance P receptor desensitization in the dorsal horn: possible involvement of receptor-G protein complexes. Brain Res (1993) 0.77
Muscarinic acetylcholine receptors in chick heart: influence of heat and N-ethylmaleimide on receptor conformations and interactions with guanine nucleotide-dependent regulatory proteins. Neurosci Lett (1985) 0.77
Fentanyl and sufentanil inhibit agonist binding to 5-HT1A receptors in membranes from the rat brain. Neuropharmacology (1991) 0.77
Role of central biogenic amines on the protection afforded by clonidine against the toxicity of soman, an irreversible cholinesterase inhibitor. Toxicol Lett (1988) 0.77
Volatile anesthetics and NMDA receptors. Enflurane inhibition of glutamate-stimulated [3H]MK-801 binding and reversal by glycine. Neurosci Lett (1991) 0.77
Effects of halothane on high affinity agonist binding and guanine nucleotide sensitivity of muscarinic acetylcholine receptors from brainstem of rat. Neuropharmacology (1987) 0.77
Competitive interaction of gallamine with multiple muscarinic receptors. Biochem Pharmacol (1982) 0.77
Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine. Pharmacol Biochem Behav (1988) 0.77
Relation of cation binding sites on synaptic vesicles to opiate action. Life Sci (1979) 0.77
Colchicine inhibits acetylcholine receptor stimulation of G protein GTPase activity in rat striatum. Pharmacol Toxicol (1991) 0.77
Mechanism of phospholipase A2-induced conduction block in bullfrog sciatic nerve. II. Biochemistry. Brain Res (1986) 0.76
Enhancement of synaptic vesicle attachment to the plasma membrane fraction by copper. Neurochem Res (1980) 0.76
Influence of acute and chronic ethanol treatment on muscarinic responses and receptor expression in Chinese hamster ovary cells. Biochem Pharmacol (1997) 0.76
Selectivity of pirenzepine in the central nervous system. I. Direct autoradiographic comparison of the regional distribution of pirenzepine and carbamylcholine binding sites. Brain Res (1987) 0.76
Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a. Mol Pharmacol (1986) 0.76
Effect of pH on muscarinic acetylcholine receptors from rat brainstem. J Neurochem (1986) 0.76
Anatoxin-a interactions with cholinergic synaptic molecules. Proc Natl Acad Sci U S A (1981) 0.75
Calcium uptake by intestinal smooth muscle: influence of alkylation. Eur J Pharmacol (1983) 0.75
A benzilate ester of pyrrolizidine and its stereochemical relationship to other psychotomimetic glycolates. Life Sci (1974) 0.75
Binding of apomorphine to neural membranes. J Neurosci Res (1977) 0.75
Monovalent cation penetration into synaptic membranes. FEBS Lett (1975) 0.75
Immobilization of opiates by membrane lipids. Mol Pharmacol (1977) 0.75
Cation binding sites on synaptic vesicles. Arch Biochem Biophys (1980) 0.75
Analysis of regional variations in the affinities of muscarinic agonists in the rat brain. Brain Res (1980) 0.75
Binding and immobilization of catecholamines by liposomes. J Neurosci Res (1977) 0.75
Fluorescence methods for drug-membrane interactions. Prog Clin Biol Res (1979) 0.75
Kinetics of interfacial ATP adsorption and anionic exchange with a synaptic membrane protein. J Neurosci Res (1976) 0.75